These findings indicate that bone-derived OPN leads to phosphorylation of WNK1 and PRAS40 and suggests that activation of these pathways may be a potential contributing mechanism underlying the functional role of bone-derived OPN in the malignant behavior of breast cancer cells. This evidence concerns the gene AKT1S1 and breast cancer.